Innovation Internet > Industries > Biotechnology > Evaluation of the National Biotechnology Strategy
 
 
 
 
 
 


(Last Reviewed :  17/09/2009 )

In 2007 Biotechnology Australia (BA) arranged for an independent evaluation of the National Biotechnology Strategy (NBS) and BA to be undertaken by Deloitte Insight Economics. This was consistent with the government requirement for terminating programs to be evaluated, given that funding for the NBS and BA ceases on 30 June 2008.

The report evaluates the performance of the NBS and BA against the criteria of appropriateness, effectiveness and efficiency, and comments on the policy grounds on which a new NBS could be sought and the key issues it may need to address. The evaluation involved significant stakeholder engagement including

  • face to face and phone interviews with 47 stakeholders
  • four roundtable discussion groups
  • an online survey with 107 responses

The final evaluation report was completed in January 2008. The report is being considered in the context of the National Innovation System Review.



View Document: to view the complete version of this document, you can:

Download Evaluation of the National Biotechnology Strategy and Biotechnology Australia (.pdf, 957KB)


Note: There may be links contained within this document which will transfer you from this website. The Department of Innovation, Industry, Science and Research does not take responsibility for the content or accuracy of external websites, nor does linking constitute any form of endorsement. Further information is provided in our disclaimer.

Note: You need Adobe Acrobat Reader 8.0 or above to view PDF files. If you do not have Adobe Acrobat Reader installed on your computer and/or can not view or print the PDF document, you can download a free copy of the software from the Adobe website.

Note: If you have a query relevant to the Department or problems accessing an attached file, please contact us.